Mucormycosis is a rare, aggressive fungal infection associated with high mortality, particularly in immuno-compromised individuals. Gastric involvement, though uncommon, poses significant diagnostic and therapeutic challenges that frequently result in poor clinical outcomes. Our case emphasizes the importance of including uncommon infectious aetiology in the evaluation of upper GI bleeding, particularly in immuno-compromised patients, to facilitate timely intervention and potentially improve outcomes.
PrakashHGhoshAKRudramurthySM, et al.A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med Mycol [Internet]2019 [cited 2023 Sep 8]; 57: 395–402. Available from: https://pubmed.ncbi.nlm.nih.gov/30085158/.
2.
ChakrabartiADasAMandalJ, et al.The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol [Internet]2006 [cited 2023 Sep 8]; 44: 335–342. Available from: https://pubmed.ncbi.nlm.nih.gov/16772227/.
3.
PatelAKaurHXessI, et al.A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect [Internet]2020 [cited 2023 Sep 8]; 26: 944.e9–944.e15. Available from: https://pubmed.ncbi.nlm.nih.gov/31811914/.
4.
ThomsonSRBadePGTaamsM, et al.Gastrointestinal mucormycosis. Br J Surg [Internet]1991 [cited 2023 Sep 8]; 78: 952–954. Available from: https://pubmed.ncbi.nlm.nih.gov/1913115/.
5.
JohnTMJacobCNKontoyiannisDP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel) [Internet]2021 [cited 2023 Sep 8]; 7: 298. Available from: https://pubmed.ncbi.nlm.nih.gov/33920755/.
6.
Fernandes Barros Brehme de AbreuBDuarteMLDos SantosLR, et al.A rare case of gastric mucormycosis in an immunocompetent patient. Soc Bras Med Trop2018; 51: 401–402.
